WHO ARE WE

Parse Biosciences, a QIAGEN company, is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, its pioneering approach has enabled groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.

Founded based on a transformative technology invented at the University of Washington, Parse has raised over $100 million and our tools are trusted 3,000 labs across the world. Our growing portfolio of products includes Evercode Whole Transcriptome, Evercode Whole Transcriptome FFPE, Evercode TCR, BCR, Gene Capture, and Trailmaker, a software tool for data analysis

Headquartered in Seattle, Washington's vibrant South Lake Union district, Parse Biosciences recently opened a 34,000 square foot headquarters and state-of-the-art...